The number of people suffering from some sort of allergy is on the rise and the demand for reliable treatments for allergic rhinitis and other allergic conditions is on the rise worldwide. The market is a mature one with a number of high profile patent losses in the near future and a strong OTC segment. Will there be a replacement for Zyrtec or Allegra in the near Future? What role will the new improved vaccines play in the next five years? Read visiongain’s new report to find out.
What is contained in the report?
The report covers all aspects of the current allergy market, including
A brief introduction into the biology of allergies
A market forecast for the world prescription market 2006-2011
Geographic breakdowns for sales revenues
A SWOT analysis of the allergic rhinitis market
Summaries and forecasts for the leading antihistamines and corticosteroids
An assessment of the drivers and restraints of the market
A discussion of the strategy of Rx-OTC switching
A review of the OTC market for allergic rhinitis
Analysis of treatments of eczema and allergic conjunctivitis
This report consists of over 100 pages and over 50 tables and figures.
Please Note: Reports are sold based on the user licenses indicated. The Publisher delivers the report in Flash format via the publisher website, allowing viewing and printing capabilities only. Within one to two business days after placing the order, the Publisher will email the client with information on accessing their purchase. Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.
(0 items)
